Most Recent
A judge has slapped a $10 million fine on online supplement company Peptide Clinics for advertising prescription-only drugs in breach of the Therapeutic Goods Act.
Insolvency firm Kordamentha has filed proceedings against ten former directors of the Arrium Group, accusing them of breaching of their duties to prevent insolvent trading after the steel giant collapsed with almost $4 billion in debt.
A judge overseeing a lease dispute in relation to a Brisbane CBD office tower has slashed a $43.2 million statutory demand against construction company Grocon by more than two thirds, finding property management firm Dexus was unreasonable to demand payment just two business days after issuing its invoices.
Pitcher Partners has lost it challenge to a ruling socking it with a $5.6 million bill for an accounting error concealed from client Neville's Bus Service, with an appeals court saying there was a "clear and principled basis" to require the accounting firm to pay the sum awarded for loss and damage to the transport company.
Defence shipbuilder Austal faces legal action by the corporate regulator challenging claims of privilege over documents sought as part of a probe into disclosures linked to cost overruns on the company's $4 billion US Navy ship-building program.
The settlement of the Discovery Metals investor class action against KPMG has experienced another setback, after scheme administrator Grant Thornton flagged a potential conflict of interest in acting as a costs contradictor over Piper Alderman’s controversial $3.5 million legal bill.
Mylan has launched a lawsuit against Cipla for allegedly copying the get-up of its blockbuster cholesterol drug Lipidil, after losing a bid to block Cipla and Sun Pharma from selling generic versions of the drug while it appeals a ruling invalidating several claims of its patents.
Patents at the centre of a high stakes IP dispute between tech giants Motorola and Hytera have significantly more than the necessary “scintilla of inventiveness” to be deemed valid, Motorola said on the first day of a month-long trial.
A unit of Boehringer Ingelheim has been given more time to oppose a proposed patent by rival drug maker Intervet, after the German drug company's lawyers sent an email with the wrong opposition deadline.
Blue Sky Alternative Investments has reached a confidential settlement of its case against three former directors and two investment firms over an alleged raid on the fund manager's confidential database.